Refined fructose and cancer

Expert Opinion on Therapeutic Targets

Volumn 15, Issue 9, 2011, Pages 1049-1059

  Liu, Haibo ^a   Heaney, Anthony P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Carbohydrate metabolism; Fructose; Glut 5; Obesity

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; CYTOKINE; DNA; FATTY ACID; FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER 5; INSULIN; LEPTIN; NUCLEIC ACID; PURINE; REACTIVE OXYGEN METABOLITE; SEX HORMONE BINDING GLOBULIN; SMALL INTERFERING RNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SUGAR; TRANSFERASE INHIBITOR; TRANSKETOLASE; TRANSKETOLASE INHIBITOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER RISK; CARBOHYDRATE METABOLISM; CARCINOGENESIS; CELL METABOLISM; CELL PROLIFERATION; CELL TRANSFORMATION; CHRONIC INFLAMMATION; DIABETES MELLITUS; DNA DAMAGE; DNA STRAND BREAKAGE; ENERGY METABOLISM; FATTY ACID SYNTHESIS; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; MITOGENESIS; NEOPLASM; NONHUMAN; NUCLEIC ACID SYNTHESIS; OBESITY; PANCREAS CANCER; PURINE SYNTHESIS; REVIEW; SUGAR INTAKE; TUMOR MICROENVIRONMENT; TUMOR PROMOTION;

ANIMALS; CELL PROLIFERATION; DIETARY CARBOHYDRATES; DNA DAMAGE; DRUG DELIVERY SYSTEMS; FRUCTOSE; HUMANS; INFLAMMATION; NEOPLASMS; REACTIVE OXYGEN SPECIES; RISK FACTORS; TUMOR MICROENVIRONMENT;

EID: 80051765397     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2011.588208     Document Type: Review

References (59)

1. van den Brink GR, Offerhaus GJ. The morphogenetic code and colon cancer development. Cancer Cell 2007;15:109-17
2. Levy-Lahad E, Friedman E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 2007;96:11-15
3. Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 2006;116:1093-106
4. Yanke BV, Salzhauer EW, Colon I. Is race a positive predictor of cancer on repeat prostate biopsy? J Urol 2006;176:1114-17
5. Chou S-Y, Grossman M, Saffer H. An economic analysis of adult obesity: Results from the behavioral risk factor surveillance system. J Health Econ 2004;23:565-87
6. National Institutes of Health: National Institute of Diabetes, Digestive and Kidney Diseases. "Statistics Related to Overweight and Obesity: The Economic Costs." Avaliable from: Http://www.win. niddk.nih.gov/statistics/ index.htm Summarizes the rapid rise in obesity with a discussion on associated diseases.
7. Putnam JJ, Allshouse JE. Food consumption, prices, and expenditures, 1970-97. Statistical bulletin No. (SB- 965) 189 pp, US Department of Agriculture, April 1999
8. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38 A good epidemiologic overview of association between obesity and various cancers.
9. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005;2(1):5
10. Gallagher EJ, LeRoith D. Insulin, insulin resistance, obesity, and cancer. Curr Diab Rep 2010;10:93-100 An excellent discussion of potential mechanisms including animal models linking obesity to cancer.
11. Pitt Henry A. Hepato-pancreato-biliary fat: The good, the bad and the ugly. HPB (Oxford) 2007;9:92-7
12. Miatello R, Risler N, Castro C, et al. Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats. Am J Hypertens 2001;14:1135-41
13. Farah V, Elased KM, Chen Y, et al. Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci 2006;130:41-50
14. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatology 2008;48:993-9
15. Higginbotham S, Zhang ZF, Lee IM, et al. Women's Health Study. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004;96:229-33
16. Giovannucci E, Rimm EB, Wolk A, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res 1998;58(3):442-7
17. Ashrafian. Cancer's sweet tooth: The janus effect of glucose metabolism. Lancet 2006;367:618-21
18. DeBerardinis RJ, Sayed N, Ditsworth D, Thompson CB. Brick by brick: Metabolism and tumor growth. Curr Opin Gen Devel 2008;18:54-61 A good review of evidence for role of altered metabolism in cancer with specific examples of metabolic enzyme mutations directly causing cancer.
19. DeBerardinis RJ. Is cancer a disease of abnormal cellular metabolism? Genet Med 2008;10:767-77
20. Enzmann H, Ohlhauser D, Dettler T, Bannasch P. Enhancement of hepatocarcinogenesis in rats by dietary fructose. Carcinogenesis 1989;10:1247-52
21. Enzmann H, Dettler T, Ohlhauser D, et al. Dietary fructose enhances the development of atypical acinar cell nodules in the pancrease of rats pretreated with N-nitrosomorpholine. Arch Geschwulstforsch 1990;60:283-7 Earliest studies reporting potential links between fructose and cellular transformation in a model of hepatoccellular cancer.
22. Monzavi-Karbassi B, Hine RJ, Stanley JS, et al. Fructose as a carbon source induces an aggressive phenotype in MDA-MB-468 breast tumor cells. Int J Oncol 2010;37:615-22 A recent study of adverse effects of fructose in breast cancer.
23. Caderni G, Luceri C, Lancioni L, et al. Dietary sucrose, glucose, fructose, and starches affect colonic functions in rats. Nutr Cancer 1996;25:179-86
24. Liu H, Huang D, McArthur DL, et al. Fructose induces transketolase to promote pancreatic cancer growth. Cancer Research 2010;70:6368-76 A study describing altered metabolism of fructose versus glucose in pancreatic and other cancers.
25. Hui H, McArthur D, Nissen N, Heaney AP. Direct spectrophotometric determination of serum fructose in pancreatic cancer patients. Pancreas 2009;38:706-12
26. Boros LG, Puigjaner J, Cascante M, et al. Oxythiamine and dehydroepianrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res 1997;57:4242-8
27. Xu X, Hausen AZ, Coy JF, Lochelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. In J Cancer 2009;124:1330-7
28. Staiger WI, Coy JF, Grobholz R, et al. Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncol Reports 2006;16:657-61
29. Lopez-Lzzaro M. Excessive superoxide anion generation plays a key role in carcinogenesis. Int J Cancer 2007;120:1378-80
30. Kim HY, Okubo T, Juneja LR, Yokozawa T. The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model. Br J Nutr 2010;103:502-12
31. Lee O, Bruce WR, Dong Q, et al. Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact 2009;178:332-9 An important paper describing the increased ability of fructose to generate harmful metabolites versus glucose.
32. Mattioli LF, Holloway NB, Thomas JH, Wood JG. Fructose, but not dextrose, induces leukocyte adherence to the mesenteric venule of the rat by oxidative stress. Pediatr Res 2010;67:352-6
33. Kohli R, Kirby M, Xanthakos SA, et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elvates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010;52:934-44
34. Ghanim H, Mohanty P, Pathak R, et al. Orange juice or fructose intake does not induce oxidative and inflammatory response. Diabetes Care 2007;30:1406-11
35. Fields M, Lewis CG, Lure MD. Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose. Free Radic Biol Med 1996;20:595-600
36. Cavarape A, Feletto F, Mercuri F, et al. High-fructose diet decreases catalase mRNA levels in rat tissues. J Endocrinol Invest 2001;24:838-45
37. Bates CJ. Glutathione and related indices in rat lenses, liver and red cells during riboflavin deficiency and its correction. Exp Eye Res 1991;53:123-30
38. Levi B, Werman MJ. Fructose triggers DNA modification and damage in an Escherichia coli plasmid. J Nutr Biochem 2001;12:235-41
39. Levi B, Werman MJ. Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells. J Nutr Biochem 2003;14:49-60
40. Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and the risk of cancer mortality in a national sample of U.S. adults: Results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiol Biomarkers Prev 2004;13:1052-6
41. Li RW, Theriault AG, Au K, et al. Citrus polymethoxylated flavones improve lipid and glucose homeostasis and modulate adipocytokines in fructose-induced insulin resistant hamsters. Life Sci 2006;79:365-73
42. Xi L, Qian Z, Xu G, et al. Beneficial impact of crocetin, a carotenoid from saffron on insulin sensitivity in fructose-fed rats. J Nutr Biochem 2007;18:64-72
43. Togashi N, Ura N, Higashiura K, et al. The contribution of skeletal muscle tumor necrosis factor- to insulin resistance and hypertension in fructose-fed rats. J Hypertens 2000;18:1605-10
44. Wang L, Higashiura K, Togashi N, et al. Effects of the Chinese medicine Jiang- Tang-Ke-Li on insulin resistance in fructose-fed rats. Hypertens Res 2001;24:303-9
45. Nakamura K, Yamagishi S, Matsui T, et al. Acarbose, an alpha-glucosidase inhibitor, decreases aortic gene expression and serum levels of monocyte chemoattractant protein-1 in fructose-fedrats. J Int Med Res 2006;34:525-30
46. D'Angelo G, Elmarakby AA, Pollock DM, et al. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 2005;46:806-11
47. Deng JY, Huang JP, Lu LS, et al. Impairment of cardiac insulin signaling and myocardial contractile performance in high cholesterol-fructose fed rats. Am J Physiol Heart Circ Physiol 2007;293:H978-87
48. Catena C, Giacchetti G, Novello M, et al. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens 2003;16:973-8
49. Ueno M, Bezerra RM, Silva MS, et al. A high-fructose diet induces changes in pp185 phosphorylation in muscle and liver of rats. Braz J Med Biol Res 2000;33:1421-7
50. McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications 2002;16:72-80
51. Kok N, Roberfroid M, Delzenne N. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 1996;45:1547-50
52. Kazumi T, Odaka H, Hozumi T, et al. Effects of dietary fructose or glucose on triglyceride production and lipogenic enzyme activities in the liver of Wistar fatty rats, an animal model of NIDDM. Endocr J 1997;44:239-45
53. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007;23:62-8
54. Miyazaki M, Dobrzyn A, Man WC, et al. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem 2004;279:25164-71
55. Ettinger SL, Sobel R, Whitmore TG, et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004;64:2212-21
56. Zamora-Leon SP, Golde DW, Concha II, et al. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA 1996;93:1847-52
57. Alejandro Godoy, Viviana Ulloa, Federico Rodriguez, et al. Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol 2006;207:614-27
58. Chan KK, Chan JYW, Chung KKW, Fung K-P. Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5. J Cell Biochem 2004;93:1134-42 An important paper describing rationale for targeting fructose-mediated actions in cancer.
59. Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer? Am J Pathol 2006;169:1505-22